by
Lisa Chamoff, Contributing Reporter | October 10, 2022
From the October 2022 issue of HealthCare Business News magazine
The Brainlab Novalis SRS Registry will help professionals share best practices from their clinics.
“At Brainlab we believe that every treatment should be based on a holistic view of each patient’s situation and clinical history,” said Gabi Geiselmann, manager of product management and marketing for Novalis Knowledge at Brainlab. “With the Brainlab Novalis SRS Registry we want to support all clinical specialties involved in radiosurgical diagnoses and treatments with tools for reporting, intelligently structuring, and visualizing clinical data from different sources to advance patient-specific treatment decisions.”
Ad Statistics
Times Displayed: 890
Times Visited: 99 You can’t fix what you can’t see. With enhanced visibility and monitoring of your devices and network, ReadySee™ can help you stay ahead of issues before they disrupt patient care.
Elekta
In May 2022, Elekta unveiled Elekta Esprit, a new Leksell Gamma Knife radiosurgery platform. This includes the new headframe, Vantage, which was released in late 2021.
Improved workflow and operator experience is at the heart of the redesigned onboard monitor and makes patient setup and positioning easier, said Verena Schiller, executive vice president of Elekta’s Neuro business line. This new operator experience is extended to the control area through a reduced control system footprint and ergonomic design of the control panel.
“With Elekta Esprit, we’ve worked to build a kinder, gentler patient experience,” Schiller said. “The Vantage headframe is designed to improve targeting through improved imaging, while the open-face design is more patient friendly, allowing eating and drinking while in the frame.”
Esprit also offers high-resolution digital video and clear audio for improved communication between the patient and their care team, with improved sound, including an input where patients can listen to music or podcasts.
Elekta Esprit also offers submillimeter — down to 0.3 millimeters — precision and treatment planning that can be completed by the end user in less than 60 seconds, compared to the 0.8- to 1-millimeter precision associated with most competitive systems, according to the company. In addition, Elekta Esprit offers two to 21 times lower dose outside the target than competing systems.
MagnetTx
On May 4, 2022, Canada-based MagnetTx received clearance from the FDA for Aurora-RT, an innovative radiation therapy system that combines MR and linear accelerator to help cancer patients. Now, the MR-LINAC can be sold throughout the U.S.
“Aurora-RT offers all of the radiation positioning advantages of conventional linear acccelerators with CBCT while adding on board MR during irradiation,” said Mike Cogswell, president and CEO of MagnetTx. “Its unique open (110 x 60 cm bore) bi-planar rotating parallel MR field design avoids dose-perturbation (electron-return effects) allowing the use of conventional treatment planning systems, offers placement of the patient to the optimal position improving set-up and throughput time, offers larger number of indications, such as tangential fields, while minimizing claustrophobia.”
